Peptide–drug conjugates as effective prodrug strategies for targeted delivery

Advanced Drug Delivery Reviews

Volumn 110-111, Issue , 2017, Pages 112-126

  Wang, Yin ^a   Cheetham, Andrew G ^a   Angacian, Garren ^b   Su, Hao ^a   Xie, Lisi ^a   Cui, Honggang ^a,c,d  

^a Johns Hopkins University   (United States)

^b Johns Hopkins University   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Cancer; Conjugated chemistry; Drug amphiphiles; Drug delivery; Peptide drug conjugates

Indexed keywords

AMPHIPHILES; CHEMICAL ANALYSIS; CHEMOTHERAPY; DISEASES; DRUG DELIVERY; MEDICAL NANOTECHNOLOGY; MOLECULES;

ACTIVE PHARMACEUTICAL INGREDIENTS; CANCER; CANCER CHEMOTHERAPY; PEPTIDE DRUGS; SELF-ASSEMBLING PEPTIDES; TARGETED DELIVERY; TARGETED DRUG DELIVERY; THERAPEUTIC AGENTS;

PEPTIDES;

AMPHOPHILE; CAMPTOTHECIN; CELL PENETRATING PEPTIDE; CISPLATIN; CREMOPHOR; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOSPORIN A; DEXAMETHASONE; DITHIOTHREITOL; DOXORUBICIN; GELATINASE A; GELATINASE B; GEMCITABINE; GLUTATHIONE; PACLITAXEL; PEPTIDE; PRODRUG; NANOFIBER;

AMINO TERMINAL SEQUENCE; BIOCOMPATIBILITY; CANCER CHEMOTHERAPY; CARBOXY TERMINAL SEQUENCE; CHEMICAL BOND; CLINICAL EFFECTIVENESS; CONCENTRATION RESPONSE; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HYDROGEL; HYDROPHILICITY; HYDROPHOBICITY; LIPOPHILICITY; MOLECULAR PROBE; NANOMEDICINE; NONHUMAN; PANCREAS CANCER; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; SEQUENCE ANALYSIS; THERANOSTIC NANOMEDICINE; ADMINISTRATION AND DOSAGE; ANIMAL; CHEMISTRY; DRUG DESIGN; NEOPLASM; PROCEDURES;

ANIMALS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; HYDROGELS; NANOFIBERS; NEOPLASMS; PEPTIDES; PRODRUGS;

EID: 84996957342     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2016.06.015     Document Type: Review

References (155)

1. Peppas, N.A., Hilt, J.Z., Khademhosseini, A., Langer, R., Hydrogels in biology and medicine: from molecular principles to bionanotechnology. Adv. Mater. 18 (2006), 1345–1360.
2. Edwards, D.A., Hanes, J., Caponetti, G., Hrkach, J., BenJebria, A., Eskew, M.L., Mintzes, J., Deaver, D., Lotan, N., Langer, R., Large porous particles for pulmonary drug delivery. Science 276 (1997), 1868–1871.
3. Peer, D., Karp, J.M., Hong, S., FaroKHzad, O.C., Margalit, R., Langer, R., Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2 (2007), 751–760.
4. Farokhzad, O.C., Cheng, J.J., Teply, B.A., Sherifi, I., Jon, S., Kantoff, P.W., Richie, J.P., Langer, R., Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 6315–6320.
5. Langer, R., Drug delivery and targeting. Nature 392 (1998), 5–10.
6. Torchilin, V.P., Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nat. Rev. Drug Discov. 13 (2014), 813–827.
7. Brannon-Peppas, L., Blanchette, J.O., Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev. 64 (2012), 206–212.
8. Torchilin, V.P., Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov. 4 (2005), 145–160.
9. Mura, S., Nicolas, J., Couvreur, P., Stimuli-responsive nanocarriers for drug delivery. Nat. Mater. 12 (2013), 991–1003.
10. Lin, R., Cheetham, A.G., Zhang, P., Lin, Y.A., Cui, H., Supramolecular filaments containing a fixed 41% paclitaxel loading. Chem. Commun. 49 (2013), 4968–4970.
11. Kaneda, Y., Virosomes: evolution of the liposome as a targeted drug delivery system. Adv. Drug Deliv. Rev. 43 (2000), 197–205.
12. Kratz, F., Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J. Control. Release 132 (2008), 171–183.
13. Chari, R.V., Miller, M.L., Widdison, W.C., Antibody-drug conjugates: an emerging concept in cancer therapy. Angew. Chem. Int. Ed. 53 (2014), 3796–3827.
14. Su, H., Koo, J.M., Cui, H., One-component nanomedicine. J. Control. Release 219 (2015), 383–395.
15. Duncan, R., Polymer conjugates as anticancer nanomedicines. Nat. Rev. Cancer 6 (2006), 688–701.
16. Khandare, J., Minko, T., Polymer–drug conjugates: progress in polymeric prodrugs. Prog. Polym. Sci. 31 (2006), 359–397.
17. Schrama, D., Reisfeld, R.A., Becker, J.C., Antibody targeted drugs as cancer therapeutics. Nat. Rev. Drug Discov. 5 (2006), 147–159.
18. MacEwan, S.R., Chilkoti, A., Elastin-like polypeptides: biomedical applications of tunable biopolymers. Biopolymers 94 (2010), 60–77.
19. MacKay, J.A., Chen, M., McDaniel, J.R., Liu, W., Simnick, A.J., Chilkoti, A., Self-assembling chimeric polypeptide-doxorubicin conjugate nanoparticles that abolish tumours after a single injection. Nat. Mater. 8 (2009), 993–999.
20. Shen, Y., Jin, E., Zhang, B., Murphy, C.J., Sui, M., Zhao, J., Wang, J., Tang, J., Fan, M., Van Kirk, E., Murdoch, W.J., Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery. J. Am. Chem. Soc. 132 (2010), 4259–4265.
21. Wang, Y., Wang, H., Chen, Y., Liu, X., Jin, Q., Ji, J., Biomimetic pseudopolyrotaxane prodrug micelles with high drug content for intracellular drug delivery. Chem. Commun. 49 (2013), 7123–7125.
22. Aida, T., Meijer, E.W., Stupp, S.I., Functional supramolecular polymers. Science 335 (2012), 813–817.
23. O'Leary, L.E., Fallas, J.A., Bakota, E.L., Kang, M.K., Hartgerink, J.D., Multi-hierarchical self-assembly of a collagen mimetic peptide from triple helix to nanofibre and hydrogel. Nat. Chem. 3 (2011), 821–828.
24. Ellis-Behnke, R.G., Liang, Y.X., You, S.W., Tay, D.K., Zhang, S., So, K.F., Schneider, G.E., Nano neuro knitting: peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 5054–5059.
25. Hartgerink, J.D., Beniash, E., Stupp, S.I., Self-assembly and mineralization of peptide-amphiphile nanofibers. Science 294 (2001), 1684–1688.
26. Cui, H., Webber, M.J., Stupp, S.I., Self-assembly of peptide amphiphiles: from molecules to nanostructures to biomaterials. Biopolymers 94 (2010), 1–18.
27. Scott, A.M., Wolchok, J.D., Old, L.J., Antibody therapy of cancer. Nat. Rev. Cancer 12 (2012), 278–287.
28. Urry, W., Parker, T.M., Reid, M.C., Gowda, D.C., Biocompatibility of the Bioelastic materials, poly(GVGVP) and its γ-irradiation cross-linked matrix: summary of generic biological test results. J. Bioact. Compat. Polym. 6 (1991), 263–282.
29. Shamji, M.F., Betre, H., Kraus, V.B., Chen, J., Chilkoti, A., Pichika, R., Masuda, K., Setton, L.A., Development and characterization of a fusion protein between thermally responsive elastin-like polypeptide and interleukin-1 receptor antagonist: sustained release of a local antiinflammatory therapeutic. Arthritis Rheum. 56 (2007), 3650–3661.
30. Hu, Y., Lin, R., Zhang, P., Fern, J., Cheetham, A.G., Patel, K., Schulman, R., Kan, C., Cui, H., Electrostatic-driven lamination and untwisting of β-sheet assemblies. ACS Nano 10 (2016), 880–888.
31. Ma, W., Cheetham, A.G., Cui, H., Building nanostructures with drugs. Nano Today 11 (2016), 13–30.
32. Yasuhiro Matsumura, H.M., A new concept for macromolecular therapeutics in cancer chemotherapy- mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 46 (1986), 6387–6392.
33. Priftis, D., Leon, L., Song, Z., Perry, S.L., Margossian, K.O., Tropnikova, A., Cheng, J., Tirrell, M., Self-assembly of alpha-helical polypeptides driven by complex coacervation. Angew. Chem. Int. Ed. 54 (2015), 11128–11132.
34. Schneider, J.P., Pochan, D.J., Ozbas, B., Rajagopal, K., Pakstis, L., Kretsinger, J., Responsive hydrogels from the intramolecular folding and self-assembly of a designed peptide. J. Am. Chem. Soc. 124 (2002), 15030–15037.
35. Adler-Abramovich, L., Gazit, E., The physical properties of supramolecular peptide assemblies: from building block association to technological applications. Chem. Soc. Rev. 43 (2014), 6881–6893.
36. Cai, Y., Zhan, J., Shen, H., Mao, D., Ji, S., Liu, R., Yang, B., Kong, D., Wang, L., Yang, Z., Optimized ratiometric fluorescent probes by peptide self-assembly. Anal. Chem. 88 (2016), 740–745.
37. Williams, R.J., Mart, R.J., Ulijn, R.V., Exploiting biocatalysis in peptide self-assembly. Biopolymers 94 (2010), 107–117.
38. Gelderblom, H., Verweij, J., Nooter, K., Sparreboom, A., Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur. J. Cancer 37 (2001), 1590–1598.
39. Avraamides, C.J., Garmy-Susini, B., Varner, J.A., Integrins in angiogenesis and lymphangiogenesis. Nat. Rev. Cancer 8 (2008), 604–617.
40. Desgrosellier, J.S., Cheresh, D.A., Integrins in cancer: biological implications and therapeutic opportunities. Nat. Rev. Cancer 10 (2010), 9–22.
41. Arosio, D., Casagrande, C., Advancement in integrin facilitated drug delivery. Adv. Drug Deliv. Rev. 97 (2016), 111–143.
42. Wadih Arap, R.P., Ruoslahti, E., Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279 (1998), 377–380.
43. Ryppa, C., Fichtner, I., Weber, H., Satchi-Fainaro, R., Martin, F.K., Biniossek, L., In vitro and in vivo evaluation of doxorubicin conjugates with the divalent peptide E-[c(RGDfK)2] that targets integrin αvβ3. Bioconjug. Chem. 19 (2008), 1414–1422.
44. Chen, X.Y., Hou, Y., Neamati, N., Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery. J. Med. Chem. 48 (2005), 1098–1106.
45. Choi, K.Y., Lee, S., Chen, X., Protease-activated drug development. Theranostics 2 (2012), 156–178.
46. Pozzo, A.D., Esposito, E., Dallavalle, S., Musso, L., Bargiotti, A., Pisano, C., Vesci, L., Bucci, F., Castorina, M., Foderà, R., Giannini, G., Aulicino, C., Penco, S., Novel tumor-targeted RGD peptide–camptothecin conjugates: synthesis and biological evaluation. Bioorg. Med. Chem. 18 (2010), 64–72.
47. Pozzo, A.D., Ni, M., Muzi, L., Pisano, C., Bucci, F., Vesci, L., Castorina, M., Penco, S., Conjugates of a novel 7-substituted camptothecin with RGD-peptides as αvβ3 integrin ligands: an approach to tumor-targeted therapy. Bioconjug. Chem. 21 (2010), 1956–1967.
48. Goun, E.A., Pillow, T.H., Jones, L.R., Rothbard, J.B., Wender, P.A., Molecular transporters: synthesis of oligoguanidinium transporters and their application to drug delivery and real-time imaging. Chembiochem 7 (2006), 1497–1515.
49. Lin, R., Zhang, P., Cheetham, A.G., Walston, J., Abadir, P., Cui, H., Dual peptide conjugation strategy for improved cellular uptake and mitochondria targeting. Bioconjug. Chem. 26 (2015), 71–77.
50. Stanzl, E.G., Trantow, B.M., Vargas, J.R., Wender, P.A., Fifteen years of cell-penetrating, guanidinium-rich molecular transporters: basic science, research tools, and clinical applications. Acc. Chem. Res. 46 (2013), 2944–2954.
51. Vargas, J.R., Stanzl, E.G., Teng, N.N., Wender, P.A., Cell-penetrating, guanidinium-rich molecular transporters for overcoming efflux-mediated multidrug resistance. Mol. Pharm. 11 (2014), 2553–2565.
52. Wender, P.A., Cooley, C.B., Geihe, E.I., Beyond cell penetrating peptides: designed molecular transporters. Drug Discov. Today Technol. 9 (2012), e49–e55.
53. Wender, P.A., Galliher, W.C., Goun, E.A., Jones, L.R., Pillow, T.H., The design of guanidinium-rich transporters and their internalization mechanisms. Adv. Drug Deliv. Rev. 60 (2008), 452–472.
54. Wright, L., Rothbard, J., Wender, P., Guanidinium rich peptide transporters and drug delivery. Curr. Protein Pept. Sci. 4 (2003), 105–124.
55. Rothbard, J.B., Jessop, T.C., Lewis, R.S., Murray, B.A., Wender, P.A., Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells. J. Am. Chem. Soc. 126 (2004), 9506–9507.
56. Wender, P.A., Mitchell, D.J., Pattabiraman, K., Pelkey, E.T., Steinman, L., Rothbard, J.B., The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc. Natl. Acad. Sci. U. S. A. 97 (2000), 13003–13008.
57. Wender, P.A., Goun, E.A., Jones, L.R., Pillow, T.H., Rothbard, J.B., Shinde, R., Contag, C.H., Real-time analysis of uptake and bioactivatable cleavage of luciferin-transporter conjugates in transgenic reporter mice. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 10340–10345.
58. Rothbard, J.B., Garlington, S., Lin, Q., Kirschberg, T., Kreider, E., McGrane, P.L., Wender, P.A., Khavari, P.A., Conjugation of arginine oligomers to cyclosporin a facilitates topical delivery and inhibition of inflammation. Nat. Med. 6 (2000), 1253–1257.
59. Chen, L., Wright, L.R., Chen, C.-H., Oliver, S.F., Wender, P.A., Mochly-Rosen, D., Molecular transporters for peptides: delivery of a cardioprotective ϵPKC agonist peptide into cells and intact ischemic heart using a transport system, R7. Chem. Biol. 8 (2001), 1123–1129.
60. Hyman, J.M., Geihe, E.I., Trantow, B.M., Parvin, B., Wender, P.A., A molecular method for the delivery of small molecules and proteins across the cell wall of algae using molecular transporters. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 13225–13230.
61. Jones, L.R., Goun, E.A., Shinde, R., Rothbard, J.B., Contag, C.H., Wender, P.A., Releasable luciferin-transporter conjugates: tools for the real-time analysis of cellular uptake and release. J. Am. Chem. Soc. 128 (2006), 6526–6527.
62. Cheng, H., Zhu, J.Y., Xu, X.D., Qiu, W.X., Lei, Q., Han, K., Cheng, Y.J., Zhang, X.Z., Activable cell-penetrating peptide conjugated prodrug for tumor targeted drug delivery. ACS Appl. Mater. Interfaces 7 (2015), 16061–16069.
63. Li, S.Y., Cheng, H., Qiu, W.X., Liu, L.H., Chen, S., Hu, Y., Xie, B.R., Li, B., Zhang, X.Z., Protease-activable cell-penetrating peptide-protoporphyrin conjugate for targeted photodynamic therapy in vivo. ACS Appl. Mater. Interfaces 7 (2015), 28319–28329.
64. Pauwels, E.K., Erba, P., Mariani, G., Gomes, C.M., Multidrug resistance in cancer: its mechanism and its modulation. Drug News Perspect. 20 (2007), 371–377.
65. Gottesman, M.M., Fojo, T., Bates, S.E., Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer 2 (2002), 48–58.
66. Ambudkar, S.V., Kimchi-Sarfaty, C., Sauna, Z.E., Gottesman, M.M., P-glycoprotein: from genomics to mechanism. Oncogene 22 (2003), 7468–7485.
67. Filipits, M., Mechanisms of cancer: multidrug resistance. Drug Discov. Today Dis. Mech. 1 (2004), 229–234.
68. Dubikovskaya, E.A., Thorne, S.H., Pillow, T.H., Contag, C.H., Wender, P.A., Overcoming multidrug resistance of small-molecule therapeutics through conjugation with releasable octaarginine transporters. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 12128–12133.
69. Zhang, P., Cheetham, A.G., Lock, L.L., Cui, H., Cellular uptake and cytotoxicity of drug-peptide conjugates regulated by conjugation site. Bioconjug. Chem. 24 (2013), 604–613.
70. Zhang, P., Lock, L.L., Cheetham, A.G., Cui, H., Enhanced cellular entry and efficacy of tat conjugates by rational design of the auxiliary segment. Mol. Pharm. 11 (2014), 964–973.
71. Liu, S., Zhang, P., Banerjee, S.R., Xu, J., Pomper, M.G., Cui, H., Design and assembly of supramolecular dual-modality nanoprobes. Nanoscale 7 (2015), 9462–9466.
72. Lock, L.L., Cheetham, A.G., Zhang, P., Cui, H., Design and construction of supramolecular nanobeacons for enzyme detection. ACS Nano 7 (2013), 4924–4932.
73. Zhang, P., Cheetham, A.G., Lock, L.L., Li, Y., Cui, H., Activatable nanoprobes for biomolecular detection. Curr. Opin. Biotechnol. 34 (2015), 171–179.
74. Wang, H., Liu, G., Gao, H., Wang, Y., A pH-responsive drug delivery system with an aggregation-induced emission feature for cell imaging and intracellular drug delivery. Polym. Chem. 6 (2015), 4715–4718.
75. Ding, D., Li, K., Liu, B., Tang, B.Z., Bioprobes based on AIE fluorogens. Acc. Chem. Res. 46 (2013), 2441–2453.
76. Hong, Y., Lam, J.W., Tang, B.Z., Aggregation-induced emission. Chem. Soc. Rev. 40 (2011), 5361–5388.
77. Liang, J., Tang, B.Z., Liu, B., Specific light-up bioprobes based on AIEgen conjugates. Chem. Soc. Rev. 44 (2015), 2798–2811.
78. Wang, H., Huang, Y., Zhao, X., Gong, W., Wang, Y., Cheng, Y., A novel aggregation-induced emission based fluorescent probe for an angiotensin converting enzyme (ACE) assay and inhibitor screening. Chem. Commun. 50 (2014), 15075–15078.
79. Zhang, R., Yuan, Y., Liang, J., Kwok, R.T., Zhu, Q., Feng, G., Geng, J., Tang, B.Z., Liu, B., Fluorogen-peptide conjugates with tunable aggregation-induced emission characteristics for bioprobe design. ACS Appl. Mater. Interfaces 6 (2014), 14302–14310.
80. Yuan, Y., Kwok, R.T., Tang, B.Z., Liu, B., Targeted theranostic platinum(IV) prodrug with a built-in aggregation-induced emission light-up apoptosis sensor for noninvasive early evaluation of its therapeutic responses in situ. J. Am. Chem. Soc. 136 (2014), 2546–2554.
81. Yuan, Y., Chen, Y., Tang, B.Z., Liu, B., A targeted theranostic platinum(IV) prodrug containing a luminogen with aggregation-induced emission (AIE) characteristics for in situ monitoring of drug activation. Chem. Commun. 50 (2014), 3868–3870.
82. Han, H., Jin, Q., Wang, Y., Chen, Y., Ji, J., The rational design of a gemcitabine prodrug with AIE-based intracellular light-up characteristics for selective suppression of pancreatic cancer cells. Chem. Commun. 51 (2015), 17435–17438.
83. Yuan, Y., Kwok, R.T., Zhang, R., Tang, B.Z., Liu, B., Targeted theranostic prodrugs based on an aggregation-induced emission (AIE) luminogen for real-time dual-drug tracking. Chem. Commun. 50 (2014), 11465–11468.
84. Lock, L.L., Tang, Z., Keith, D., Reyes, C., Cui, H., Enzyme-specific doxorubicin drug beacon as drug-resistant theranostic molecular probes. ACS Macro Lett. 4 (2015), 552–555.
85. Li, S.-Y., Liu, L.-H., Rong, L., Qiu, W.-X., Jia, H.-Z., Li, B., Li, F., Zhang, X.-Z., A dual-FRET-based versatile prodrug for real-time drug release monitoring and in situ therapeutic efficacy evaluation. Adv. Funct. Mater. 25 (2015), 7317–7326.
86. Urano, Y., Asanuma, D., Hama, Y., Koyama, Y., Barrett, T., Kamiya, M., Nagano, T., Watanabe, T., Hasegawa, A., Choyke, P.L., Kobayashi, H., Selective molecular imaging of viable cancer cells with pH-activatable fluorescence probes. Nat. Med. 15 (2009), 104–109.
87. Yu, M.K., Jeong, Y.Y., Park, J., Park, S., Kim, J.W., Min, J.J., Kim, K., Jon, S., Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo. Angew. Chem. Int. Ed. 47 (2008), 5362–5365.
88. Lee, K.Y., Mooney, D.J., Hydrogels for tissue engineering. Chem. Rev. 101 (2001), 1869–1880.
89. Liang, G., Yang, Z., Zhang, R., Li, L., Fan, Y., Kuang, Y., Gao, Y., Wang, T., Lu, W.W., Xu, B., Supramolecular hydrogel of αD-amino acid dipeptide for controlled drug release in vivo. Langmuir 25 (2009), 8419–8422.
90. Peppas, N., Hydrogels in pharmaceutical formulations. Eur. J. Pharm. Biopharm. 50 (2000), 27–46.
91. Yang, Z., Liang, G., Xu, B., Enzymatic hydrogelation of small molecules. Acc. Chem. Res. 41 (2008), 315–326.
92. Zhao, F., Ma, M.L., Xu, B., Molecular hydrogels of therapeutic agents. Chem. Soc. Rev. 38 (2009), 883–891.
93. Hamidi, M., Azadi, A., Rafiei, P., Hydrogel nanoparticles in drug delivery. Adv. Drug Deliv. Rev. 60 (2008), 1638–1649.
94. Hoare, T.R., Kohane, D.S., Hydrogels in drug delivery: progress and challenges. Polymer 49 (2008), 1993–2007.
95. Jeong, B., Kim, S.W., Bae, Y.H., Thermosensitive sol–gel reversible hydrogels. Adv. Drug Deliv. Rev. 54 (2002), 37–51.
96. Estroff, L.A., Hamilton, A.D., Water gelation by small organic molecules. Chem. Rev. 104 (2004), 1201–1218.
97. Du, X., Zhou, J., Shi, J., Xu, B., Supramolecular hydrogelators and hydrogels: from soft matter to molecular biomaterials. Chem. Rev. 115 (2015), 13165–13307.
98. George, M., Weiss, R.G., Molecular organogels. Soft matter comprised of low-molecular-mass organic gelators and organic liquids. Acc. Chem. Res. 39 (2006), 489–497.
99. Terech, P., Weiss, R.G., Low molecular mass gelators of organic liquids and the properties of their gels. Chem. Rev. 97 (1997), 3133–3160.
100. Carter, J.M., Qian, Y., Foster, J.C., Matson, J.B., Peptide-based hydrogen sulphide-releasing gels. Chem. Commun. 51 (2015), 13131–13134.
101. Yang, Z., Liang, G., Guo, Z., Guo, Z., Xu, B., Intracellular hydrogelation of small molecules inhibits bacterial growth. Angew. Chem. Int. Ed. 46 (2007), 8216–8219.
102. Hu, B.H., Messersmith, P.B., Rational design of transglutaminase substrate peptides for rapid enzymatic formation of hydrogels. J. Am. Chem. Soc. 125 (2003), 14298–14299.
103. Matson, J.B., Stupp, S.I., Drug release from hydrazone-containing peptide amphiphiles. Chem. Commun. 47 (2011), 7962–7964.
104. Webber, M.J., Matson, J.B., Tamboli, V.K., Stupp, S.I., Controlled release of dexamethasone from peptide nanofiber gels to modulate inflammatory response. Biomaterials 33 (2012), 6823–6832.
105. Matson, J.B., Newcomb, C.J., Bitton, R., Stupp, S.I., Nanostructure-templated control of drug release from peptide amphiphile nanofiber gels. Soft Matter 8 (2012), 3586–3595.
106. Matson, J.B., Webber, M.J., Tamboli, V.K., Weber, B., Stupp, S.I., A peptide-based material for therapeutic carbon monoxide delivery. Soft Matter 8 (2012), 6689–6692.
107. Leikina, E., Mertts, M.V., Kuznetsova, N., Leikin, S., Type I collagen is thermally unstable at body temperature. Proc. Natl. Acad. Sci. U. S. A. 99 (2002), 1314–1318.
108. Toledano, S., Williams, R.J., Jayawarna, V., Ulijn, R.V., Enzyme-triggered self-assembly of peptide hydrogels via reversed hydrolysis. J. Am. Chem. Soc. 128 (2006), 1070–1071.
109. Williams, R.J., Smith, A.M., Collins, R., Hodson, N., Das, A.K., Ulijn, R.V., Enzyme-assisted self-assembly under thermodynamic control. Nat. Nanotechnol. 4 (2009), 19–24.
110. Yang, Z., Gu, H., Fu, D., Gao, P., Lam, J.K., Xu, B., Enzymatic formation of supramolecular hydrogels. Adv. Mater. 16 (2004), 1440–1444.
111. Zhou, J., Du, X., Xu, B., Regulating the rate of molecular self-assembly for targeting cancer cells. Angew. Chem. Int. Ed. 55 (2016), 5770–5775.
112. Zhou, J., Du, X., Yamagata, N., Xu, B., Enzyme-instructed self-assembly of small D-peptides as a multiple-step process for selectively killing cancer cells. J. Am. Chem. Soc. 138 (2016), 3813–3823.
113. Gao, Y., Kuang, Y., Guo, Z.F., Guo, Z.H., Krauss, I.J., Xu, B., Enzyme-instructed molecular self-assembly confers nanofibers and a supramolecular hydrogel of taxol derivative. J. Am. Chem. Soc. 131 (2009), 13576–13577.
114. Zhang, P.C., Cheetham, A.G., Lin, Y.A., Cui, H., Self-assembled Tat nanofibers as effective drug carrier and transporter. ACS Nano 7 (2013), 5965–5977.
115. Gao, Y., Shi, J., Yuan, D., Xu, B., Imaging enzyme-triggered self-assembly of small molecules inside live cells. Nat. Commun., 3, 2012, 1033.
116. Li, J., Gao, Y., Kuang, Y., Shi, J., Du, X., Zhou, J., Wang, H., Yang, Z., Xu, B., Dephosphorylation of D-peptide derivatives to form biofunctional, supramolecular nanofibers/hydrogels and their potential applications for intracellular imaging and intratumoral chemotherapy. J. Am. Chem. Soc. 135 (2013), 9907–9914.
117. Wang, H., Yang, C., Wang, L., Kong, D., Zhang, Y., Yang, Z., Self-assembled nanospheres as a novel delivery system for taxol: a molecular hydrogel with nanosphere morphology. Chem. Commun. 47 (2011), 4439–4441.
118. Wang, H., Yang, Z., Molecular hydrogels of hydrophobic compounds: a novel self-delivery system for anti-cancer drugs. Soft Matter 8 (2012), 2344–2347.
119. Mei, B., Miao, Q., Tang, A., Liang, G., Enzyme-instructed self-assembly of taxol promotes axonal branching. Nanoscale 7 (2015), 15605–15608.
120. Liu, H., Li, Y., Lyu, Z., Wan, Y., Li, X., Chen, H., Chen, H., Li, X., Enzyme-triggered supramolecular self-assembly of platinum prodrug with enhanced tumor-selective accumulation and reduced systemic toxicity. J. Mater. Chem. B 2 (2014), 8303–8309.
121. Li, X., Li, J., Gao, Y., Kuang, Y., Shi, J., Xu, B., Molecular nanofibers of olsalazine form supramolecular hydrogels for reductive release of an anti-inflammatory agent. J. Am. Chem. Soc. 132 (2010), 17707–17709.
122. Li, J., Kuang, Y., Gao, Y., Du, X., Shi, J., Xu, B., D-amino acids boost the selectivity and confer supramolecular hydrogels of a nonsteroidal anti-inflammatory drug (NSAID). J. Am. Chem. Soc. 135 (2013), 542–545.
123. Yang, C., Li, D., Fengzhao, Q., Wang, L., Wang, L., Yang, Z., Disulfide bond reduction-triggered molecular hydrogels of folic acid-taxol conjugates. Org. Biomol. Chem. 11 (2013), 6946–6951.
124. Li, X., Yang, C., Zhang, Z., Wu, Z., Deng, Y., Liang, G., Yang, Z., Chen, H., Folic acid as a versatile motif to construct molecular hydrogelators through conjugations with hydrophobic therapeutic agents. J. Mater. Chem. 22 (2012), 21838–21840.
125. Wang, H., Lv, L., Xu, G., Yang, C., Sun, J., Yang, Z., Molecular hydrogelators consist of taxol and short peptides/amino acids. J. Mater. Chem. 22 (2012), 16933–16938.
126. Yang, C., Wang, Z., Ou, C., Chen, M., Wang, L., Yang, Z., A supramolecular hydrogelator of curcumin. Chem. Commun. 50 (2014), 9413–9415.
127. Mao, L., Wang, H., Tan, M., Ou, L., Kong, D., Yang, Z., Conjugation of two complementary anti-cancer drugs confers molecular hydrogels as a co-delivery system. Chem. Commun. 48 (2012), 395–397.
128. Maji, S.K., Schubert, D., Rivier, C., Lee, S., Rivier, J.E., Riek, R., Amyloid as a depot for the formulation of long-acting drugs. PLoS Biol. 6 (2008), e17–e43.
129. Valery, C., Paternostre, M., Robert, B., Gulik-Krzywicki, T., Narayanan, T., Dedieu, J.C., Keller, G., Torres, M.L., Cherif-Cheikh, R., Calvo, P., Artzner, F., Biomimetic organization: octapeptide self-assembly into nanotubes of viral capsid-like dimension. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 10258–10262.
130. Couvreur, P., Stella, B., Reddy, L.H., Hillaireau, H., Dubernet, C., Desmaële, D., Lepêtre-Mouelhi, S., Rocco, F., Dereuddre-Bosquet, N., Clayette, P., Rosilio, V., Marsaud, V., Renoir, J., Cattel, L., Squalenoyl nanomedicines as potential therapeutics. Nano Lett. 6 (2006), 2544–2548.
131. Shen, Y.Q., Jin, E.L., Zhang, B., Murphy, C.J., Sui, M.H., Zhao, J., Wang, J.Q., Tang, J.B., Fan, M.H., Van Kirk, E., Murdoch, W.J., Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery. J. Am. Chem. Soc. 132 (2010), 4259–4265.
132. Dong, H.Q., Dong, C.Y., Feng, Y., Ren, T.B., Zhang, Z.H., Li, L., Li, Y.Y., Engineering of PEGlayted camptothecin into core-shell nanomicelles for improving solubility, stability and combination delivery. MedChemComm 3 (2012), 1555–1561.
133. Bao, Y., Guo, Y., Zhuang, X., Li, D., Cheng, B., Tan, S., Zhang, Z., D-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells. Mol. Pharm. 11 (2014), 3196–3209.
134. Chen, Z., Zhang, P., Cheetham, A.G., Moon, J.H., Moxley, J.W. Jr., Lin, Y.A., Cui, H., Controlled release of free doxorubicin from peptide-drug conjugates by drug loading. J. Control. Release 191 (2014), 123–130.
135. Lock, L.L., Reyes, C.D., Zhang, P., Cui, H., Tuning cellular uptake of molecular probes by rational design of their assembly into supramolecular nanoprobes. J. Am. Chem. Soc. 138 (2016), 3533–3540.
136. Kang, M., Zhang, P., Cui, H., Loverde, S.M., π–π stacking mediated chirality in functional supramolecular filaments. Macromolecules 49 (2016), 994–1001.
137. Su, H., Zhang, P.C., Cheetham, A.G., Koo, J.M., Lin, R., Masood, A., Schiapparelli, P., Quiñones-Hinojosa, A., Cui, H., Supramolecular crafting of self-assembling prodrugs with enhanced efficacy against primary cancer cells. Theranostics 6 (2016), 1065–1074.
138. Cheetham, A.G., Zhang, P., Lin, Y.A., Lock, L.L., Cui, H., Supramolecular nanostructures formed by anticancer drug assembly. J. Am. Chem. Soc. 135 (2013), 2907–2910.
139. Cheetham, A.G., Zhang, P., Lin, Y.A., Lin, R., Cui, H., Synthesis and self-assembly of a mikto-arm star dual drug amphiphile containing both paclitaxel and camptothecin. J. Mater. Chem. B 2 (2014), 7316–7326.
140. Cheetham, A.G., Ou, Y.C., Zhang, P., Cui, H., Linker-determined drug release mechanism of free camptothecin from self-assembling drug amphiphiles. Chem. Commun. 50 (2014), 6039–6042.
141. Lin, Y.A., Cheetham, A.G., Zhang, P., Ou, Y.C., Li, Y., Liu, G., Hermida-Merino, D., Hamley, I.W., Cui, H., Multiwalled nanotubes formed by catanionic mixtures of drug amphiphiles. ACS Nano 8 (2014), 12690–12700.
142. de la Rica, R., Aili, D., Stevens, M.M., Enzyme-responsive nanoparticles for drug release and diagnostics. Adv. Drug Deliv. Rev. 64 (2012), 967–978.
143. Hu, J., Zhang, G., Liu, S., Enzyme-responsive polymeric assemblies, nanoparticles and hydrogels. Chem. Soc. Rev. 41 (2012), 5933–5949.
144. Hu, Q., Katti, P.S., Gu, Z., Enzyme-responsive nanomaterials for controlled drug delivery. Nanoscale 6 (2014), 12273–12286.
145. Lin, Y.A., Ou, Y.C., Cheetham, A.G., Cui, H., Rational design of MMP degradable peptide-based supramolecular filaments. Biomacromolecules 15 (2014), 1419–1427.
146. Pires, R.A., Abul-Haija, Y.M., Costa, D.S., Novoa-Carballal, R., Reis, R.L., Ulijn, R.V., Pashkuleva, I., Controlling cancer cell fate using localized biocatalytic self-assembly of an aromatic carbohydrate amphiphile. J. Am. Chem. Soc. 137 (2015), 576–579.
147. Shi, J., Xu, B., Nanoscale assemblies of small molecules control the fate of cells. Nano Today 10 (2015), 615–630.
148. Tanaka, A., Fukuoka, Y., Morimoto, Y., Honjo, T., Koda, D., Goto, M., Maruyama, T., Cancer cell death induced by the intracellular self-assembly of an enzyme-responsive supramolecular gelator. J. Am. Chem. Soc. 137 (2015), 770–775.
149. Yang, Z.M., Xu, K.M., Guo, Z.F., Guo, Z.H., Xu, B., Intracellular enzymatic formation of nanofibers results in hydrogelation and regulated cell death. Adv. Mater. 19 (2007), 3152–3156.
150. Neubert, R.H., Potentials of new nanocarriers for dermal and transdermal drug delivery. Eur. J. Pharm. Biopharm. 77 (2011), 1–2.
151. Yuan, Y., Wang, L., Du, W., Ding, Z., Zhang, J., Han, T., An, L., Zhang, H., Liang, G., Intracellular self-assembly of taxol nanoparticles for overcoming multidrug resistance. Angew. Chem. Int. Ed. 54 (2015), 9700–9704.
152. Liang, G., Ren, H., Rao, J., A biocompatible condensation reaction for controlled assembly of nanostructures in living cells. Nat. Chem. 2 (2010), 54–60.
153. Liang, G., Ronald, J., Chen, Y., Ye, D., Pandit, P., Ma, M.L., Rutt, B., Rao, J., Controlled self-assembling of gadolinium nanoparticles as smart molecular magnetic resonance imaging contrast agents. Angew. Chem. Int. Ed. 50 (2011), 6283–6286.
154. Geng, Y., Dalhaimer, P., Cai, S., Tsai, R., Tewari, M., Minko, T., Discher, D.E., Shape effects of filaments versus spherical particles in flow and drug delivery. Nat. Nanotechnol. 2 (2007), 249–255.
155. Zhang, D., Qi, G.B., Zhao, Y.X., Qiao, S.L., Yang, C., Wang, H., In situ formation of nanofibers from purpurin18-peptide conjugates and the assembly induced retention effect in tumor sites. Adv. Mater. 27 (2015), 6125–6130.